4.4 Article

Luteolin Nanoparticle in Chemoprevention: In Vitro and In Vivo Anticancer Activity

Journal

CANCER PREVENTION RESEARCH
Volume 7, Issue 1, Pages 65-73

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1940-6207.CAPR-13-0230

Keywords

-

Categories

Funding

  1. Specialized Program of Excellence (SPORE) in Head and Neck Cancer [P50CA128613]
  2. National Cancer Institute (NCI) Centers of Cancer Nanotechnology Excellence (CCNE) Program [U54CA119338]
  3. NATIONAL CANCER INSTITUTE [P50CA128613, U01CA101244, U54CA119338] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Cancer prevention (chemoprevention) by using naturally occurring dietary agents has gained immense interest because of the broad safety window of these compounds. However, many of these compounds are hydrophobic and poorly soluble in water. They frequently display low bioavailability, poor systemic delivery, and low efficacy. To circumvent this problem, we explored a novel approach toward chemoprevention using nanotechnology to deliver luteolin, a natural compound present in green vegetables. We formulated water-soluble polymer-encapsulated Nano-Luteolin from hydrophobic luteolin, and studied its anticancer activity against lung cancer and head and neck cancer. In vitro studies demonstrated that, like luteolin, Nano-Luteolin inhibited the growth of lung cancer cells (H292 cell line) and squamous cell carcinoma of head and neck (SCCHN) cells (Tu212 cell line). In Tu212 cells, the IC50 value of Nano-Luteolin was 4.13 mu mol/L, and that of luteolin was 6.96 mu mol/L. In H292 cells, the IC50 of luteolin was 15.56 mu mol/L, and Nano-Luteolin was 14.96 mu mol/L. In vivo studies using a tumor xenograft mouse model demonstrated that Nano-Luteolin has a significant inhibitory effect on the tumor growth of SCCHN in comparison to luteolin. Our results suggest that nanoparticle delivery of naturally occurring dietary agents like luteolin has many advantages and may have potential application in chemoprevention in clinical settings.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Preclinical In Vitro, In Vivo, and Pharmacokinetic Evaluations of FLLL12 for the Prevention and Treatment of Head and Neck Cancers

Abu Syed Md Anisuzzaman, Abedul Haque, Mohammad Aminur Rahman, Dongsheng Wang, James R. Fuchs, Selwyn Hurwitz, Yuan Liu, Gabriel Sica, Fadlo R. Khuri, Zhuo (Georgia) Chen, Dong M. Shin, A. R. M. Ruhul Amin

CANCER PREVENTION RESEARCH (2016)

Article Oncology

HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models

Dongsheng Wang, Guoqing Qian, Hongzheng Zhang, Kelly R. Magliocca, Sreenivas Nannapaneni, A. R. M. Ruhul Amin, Michael Rossi, Mihir Patel, Mark El-Deiry, J. Trad Wadsworth, Zhengjia Chen, Fadlo R. Khuri, Dong M. Shin, Nabil F. Saba, Zhuo G. Chen

CLINICAL CANCER RESEARCH (2017)

Article Otorhinolaryngology

Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma

Hongzheng Zhang, Sungjin Kim, Zhengjia Chen, Sreenivas Nannapaneni, Amy Y. Chen, Charles E. Moore, Gabriel Sica, Marina Mosunjac, Minh Ly T. Nguyen, Gypsyamber D'Souza, Thomas E. Carey, Lisa A. Peterson, Jonathan B. McHugh, Martin Graham, Christine M. Komarck, Gregory T. Wolf, Heather M. Walline, Emily Bellile, James Riddell, Sara I. Pai, David Sidransky, William H. Westra, William N. William, J. Jack Lee, Adel K. El-Naggar, Robert L. Ferris, Raja Seethala, Jennifer R. Grandis, Zhuo Georgia Chen, Nabil F. Saba, Dong M. Shin

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)

Article Oncology

In Vitro and In Vivo Synergistic Antitumor Activity of the Combination of BKM120 and Erlotinib in Head and Neck Cancer: Mechanism of Apoptosis and Resistance

Abu Syed Md Anisuzzaman, Abedul Haque, Dongsheng Wang, Mohammad Aminur Rahman, Chao Zhang, Zhengjia Chen, Zhuo Georgia Chen, Dong M. Shin, A. R. M. Ruhul Amin

MOLECULAR CANCER THERAPEUTICS (2017)

Article Biochemistry & Molecular Biology

Structure-Based Design of Novel Biphenyl Amide Antagonists of Human Transient Receptor Potential Cation Channel Subfamily M Member 8 Channels with Potential Implications in the Treatment of Sensory Neuropathies

V. Blair Journigan, Zhiwei Feng, Saifur Rahman, Yuanqiang Wang, A. R. M. Ruhul Amin, Colleen E. Heffner, Nicholas Bachtel, Siyi Wang, Sara Gonzalez-Rodriguez, Asia Fernandez-Carvajal, Gregorio Fernandez-Ballester, Jacob K. Hilton, Wade D. Van Horn, Antonio Ferrer-Montiel, Xiang-Qun Xie, Taufiq Rahman

ACS CHEMICAL NEUROSCIENCE (2020)

Correction Oncology

FLLL12 induces apoptosis in lung cancer cells through a p53/p73-independent but death receptor 5-dependent pathway (vol 363, pg 166, 2015)

Abedul Haque, Mohammad Aminur Rahman, James R. Fuchs, Zhuo Chen (Georgia), Fadlo R. Khuri, Dong M. Shin, A. R. M. Ruhul Amin

CANCER LETTERS (2021)

Editorial Material Oncology

Editor's Note: The Pivotal Role of Integrin β1 in Metastasis of Head and Neck Squamous Cell Carcinoma

Dongsheng Wang, Susan Mueller, A. R. M. Ruhul Amin, Donghai Huang, Ling Su, Zhongliang Hu, Mohammad Aminur Rahman, Sreenivas Nannapaneni, Lydia Koenig, Zhengjia Chen, Mourad Tighiouart, Dong M. Shin, Zhuo G. Chen

CLINICAL CANCER RESEARCH (2020)

Review Oncology

Perspectives on natural compounds in chemoprevention and treatment of cancer: an update with new promising compounds

Abedul Haque, Daniel Brazeau, Arm R. Amin

Summary: Although cancer is the second deadliest disease worldwide, recent advances in precision treatments are promising. However, challenges remain due to the heterogeneity and mutational burdens of cancer cells. Chemoprevention, especially with natural dietary compounds, is considered a rational and appealing strategy to prevent carcinogenesis, particularly in high-risk populations.

EUROPEAN JOURNAL OF CANCER (2021)

Article Oncology

Combination of resveratrol and green tea epigallocatechin gallate induces synergistic apoptosis and inhibits tumor growth in vivo in head and neck cancer models

A. R. M. Ruhul Amin, Dongsheng Wang, Sreenivas Nannapaneni, Rajan Lamichhane, Zhuo Georgia Chen, Dong M. Shin

Summary: The combination of green tea epigallocatechin gallate (EGCG) and resveratrol has synergistic growth inhibitory effects on head and neck cancer cells, increasing apoptosis and inhibiting tumor growth by suppressing the AKT-mTOR signaling pathway. These findings suggest a potential clinical application for chemoprevention and treatment of head and neck cancer.

ONCOLOGY REPORTS (2021)

Article Chemistry, Medicinal

Structural and in Vitro Functional Characterization of a Menthyl TRPM8 Antagonist Indicates Species-Dependent Regulation

V. Blair Journigan, David Alarcon-Alarcon, Zhiwei Feng, Yuanqiang Wang, Tianjian Liang, Denise C. Dawley, A. R. M. Ruhul Amin, Camila Montano, Wade D. Van Horn, Xiang-Qun Xie, Antonio Ferrer-Montiel, Asia Fernandez-Carvajal

Summary: TRPM8 antagonists derived from its cognate ligand, (-)-menthol, are underrepresented. In this study, we determined the absolute stereochemistry of a well-known TRPM8 antagonist and explored its antagonist effects on human TRPM8, demonstrating its novel potential as a chemical tool for studying hTRPM8 pharmacology.

ACS MEDICINAL CHEMISTRY LETTERS (2021)

Review Pharmacology & Pharmacy

Perspectives for synthetic curcumins in chemoprevention and treatment of cancer: An update with promising analogues

Adeoluwa Adeluola, Abu Hasanat Md Zulfiker, Daniel Brazeau, A. R. M. Ruhul Amin

Summary: Curcumin, a compound extracted from turmeric, has been extensively studied for its anti-inflammatory, antioxidant, antimicrobial, and anti-tumour activities. Despite its potential as an anti-cancer agent, its clinical application is hindered by poor solubility and bioavailability, prompting researchers to explore novel formulation techniques and synthesis of analogues. Current research indicates promising results for the synthetic analogues of curcumin in the management of cancer.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Article Biochemistry & Molecular Biology

Context-dependent activation of p53 target genes and induction of apoptosis by actinomycin D in aerodigestive tract cancers

Adeoluwa A. Adeluola, Nana Bosomtwe, Timothy E. Long, A. R. M. Ruhul Amin

Summary: This study evaluated the anti-tumor efficacy and mechanism of action of ActD in aerodigestive tract cancers. Results showed that ActD strongly inhibited the growth of aerodigestive tract cancer cells and induced efficient apoptosis. Mechanistic studies revealed that ActD increased the expression of p53 and influenced its downstream targets.

APOPTOSIS (2022)

Article Oncology

Socioeconomic Factors Influence the Impact of Tumor HPV Status on Outcome of Patients With Oropharyngeal Squamous Cell Carcinoma

Jennifer A. Marks, Jeffrey M. Switchenko, Conor E. Steuer, Martha Ryan, Mihir R. Patel, Mark W. McDonald, Kristin Higgins, Johnathan J. Beitler, Dong M. Shin, Theresa W. Gillespie, Nabil F. Saba

Summary: The study found that in patients with oropharyngeal squamous cell carcinoma, HPV-positive patients with private insurance had improved overall survival compared to those without insurance; HPV-negative patients with private insurance also had improved survival compared to those without insurance. Additionally, there were statistical differences in the impact of insurance status, rural-urban status, and facility location on survival between HPV-positive and HPV-negative patients.

JCO ONCOLOGY PRACTICE (2021)

Correction Oncology

In Vitro and In Vivo Synergistic Antitumor Activity of the Combination of BKM120 and Erlotinib in Head and Neck Cancer: Mechanism of Apoptosis and Resistance (vol 16, pg 729, 2017)

Abu Syed Md Anisuzzaman, Abedul Haque, Dongsheng Wang, Mohammad Aminur Rahman, Chao Zhang, Zhengjia Chen, Zhuo Georgia Chen, Dong M. Shin, A. R. M. Ruhul Amin

MOLECULAR CANCER THERAPEUTICS (2020)

Article Oncology

Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma

Frederico O. Gleber-Netto, Mei Zhao, Sanchit Trivedi, Jiping Wang, Samar Jasser, Christina McDowell, Humam Kadara, Jiexin Zhang, Jing Wang, William N. William, J. Jack Lee, Minh Ly Nguyen, Sara I. Pai, Heather M. Walline, Dong M. Shin, Robert L. Ferris, Thomas E. Carey, Jeffrey N. Myers, Curtis R. Pickering

CANCER (2018)

No Data Available